• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Trichology . Telogen Effluvium Following Coronavirus Disease-2019 Infection: A Retrospective Study of 113 Cases

tetano

Editor, Senior Moderator
Int J Trichology


. 2025 Jan-Feb;17(1):32-35.
doi: 10.4103/ijt.ijt_38_22. Epub 2025 Jun 23. Telogen Effluvium Following Coronavirus Disease-2019 Infection: A Retrospective Study of 113 Cases

Namrata Chhabra[SUP] 1 [/SUP], C Anju George[SUP] 1 [/SUP], Satyaki Ganguly[SUP] 1 [/SUP]



Affiliations
Abstract

Background: Telogen effluvium (TE) is self limiting diffuse hair loss occurring 3-4 months after a triggering event. There is scarcity of data on TE as possible sequelae of COVID-19.
Methods: We assessed 113 cases of TE occurring after SARS-CoV-2 infection as a retrospective study.
Results: Most of the patients belonged to the age group 18-30 years and were females (85.8%). Most of the patients (92%) had acute TE. The median duration of hair loss was 2 months. Trichodynia and pruritus were the common associated complaints. Hair pull test was positive in 54.9% patients. Trichoscopy showed short regrowing hairs in 61.2% patients and empty hair follicles in 77.9% patients. Ferritin, vitamin D and Vitamin B12 deficiency was seen in 27.4%, 38.1% and 20.4% patients respectively. TE was seen more commonly with symptomatic COVID infection (93% patients).
Conclusion: TE occurring after SARS-CoV-2 infection calls for assessment of micronutrient deficiency, as there appears to be an association between COVID-19 infection and nutritional deficiency. Although acute TE is the most common presentation, relapse in chronic TE might also occur as sequelae of COVID-19 infection.

Keywords: Coronavirus disease-2019; telogen effluvium; trichoscopy.

 
Back
Top Bottom